Most cited papers from BTB Pharma (Sweden)

The most cited paper from BTB Pharma (Sweden) is "The epidemiology and societal costs of myasthenia gravis in Norway: A non‐interventional study using national registry data" (Ingrid Engebretsen, Nils Erik Gilhus, Ivar Sønbø Kristiansen et al., 2024), with 23 citations. Next come "A Role for the Non-Receptor Tyrosine Kinase Abl2/Arg in Experimental Neuroinflammation" (10) and "AB1042 Dynamic contrast-enhanced magnetic resonance imaging in a randomized placebo-controlled rheumatoid arthritis trial – impact of applying joint coverage quality criteria" (0).

Showing 3 of 3 papers. Every paper is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.